Millipore Sigma Vibrant Logo

444147 HCV NS3/4A Protease, Recombinant, E. coli

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Hepatitis C Virus NS3/4A Protease, Recombinant, E. coli.

444147
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information
      Description
      Overview

      This product has been discontinued.





      Recombinant, human HCV NS3/4A protease expressed in E. coli and purified by affinity chromatography using FPLC. HCV is a positive, single-stranded RNA virus of the Flaviviridae family that encodes a polyprotein precursor of about 3,000 amino acids. It is a common cause of chronic liver disease. HCV NS3/4A is an essential enzyme for viral replication. It is believed that HCV NS3/4A protease could play an important role in a treatment of hepatitis C infection.
      Catalogue Number444147
      Brand Family Calbiochem®
      SynonymsHepatitis C Virus NS3/4A Protease, Recombinant, E. coli.
      References
      ReferencesDe Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.
      Product Information
      Unit of DefinitionOne unit is defined as 1 ng of purified protein.
      FormLiquid
      FormulationIn 500 mM KCl, 20 mM Tris-HCl, 1 mM DTT, 0.2 mM EDTA, 20% glycerol, pH 8.0.
      Applications
      Biological Information
      Biological activity20-200 ng is sufficient for an in vitro protease assay
      Purity≥95% by SDS-PAGE
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      444147 0

      Documentation

      Referencias bibliográficas

      Visión general referencias
      De Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-June-2008 RFH
      SynonymsHepatitis C Virus NS3/4A Protease, Recombinant, E. coli.
      DescriptionRecombinant, human HCV NS3/4A protease expressed in E. coli and purified by affinity chromatography using FPLC. HCV is a positive, single-stranded RNA virus in the Flaviviridae family that encodes a polyprotein precursor of about 3,000 amino acids. It is a common cause of chronic liver disease. HCV NS3/4A is an essential enzyme for viral replication. It is believed that HCV NS3/4A protease could play an important role in a treatment of hepatitis C patients.
      FormLiquid
      FormulationIn 500 mM KCl, 20 mM Tris-HCl, 1 mM DTT, 0.2 mM EDTA, 20% glycerol, pH 8.0.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥95% by SDS-PAGE
      Biological activity20-200 ng is sufficient for an in vitro protease assay
      Unit definitionOne unit is defined as 1 ng of purified protein.
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesDe Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.